STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Teladoc Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Teladoc Health (TDOC): Schedule 13G/A update on ownership

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen reported beneficial ownership of 5,795,178 Teladoc common shares, representing 3.3% of the class as of September 30, 2025. The filers report shared voting and dispositive power over 5,795,178 shares and no sole voting or dispositive power.

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Teladoc. This amendment formalizes current holdings and roles among the reporting persons, including Mr. Cohen’s indirect control of the reporting entities.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/14/2025

FAQ

What did TDOC disclose in this Schedule 13G/A?

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen reported 5,795,178 Teladoc shares, or 3.3% of the class, as of September 30, 2025.

How much of Teladoc (TDOC) does Point72 report owning?

They reported beneficial ownership of 5,795,178 shares, equal to 3.3% of Teladoc’s outstanding common stock.

What voting and dispositive power did the filers report?

They disclosed shared voting power over 5,795,178 shares and shared dispositive power over 5,795,178 shares, with no sole power in either case.

Who are the reporting persons in the TDOC 13G/A?

The reporting persons are Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen.

Does the filing indicate any intent to influence control of Teladoc?

No. The certification states the securities were not acquired and are not held to change or influence control.

What is the relevant date for the ownership figures?

The ownership information is reported as of the close of business on September 30, 2025.
Teladoc Health Inc

NYSE:TDOC

TDOC Rankings

TDOC Latest News

TDOC Latest SEC Filings

TDOC Stock Data

1.25B
175.40M
0.99%
74.28%
13.03%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK